Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$194M |
| 2 |
Oracle
ORCL
|
+$159M |
| 3 |
AutoZone
AZO
|
+$159M |
| 4 |
Vanguard Dividend Appreciation ETF
VIG
|
+$157M |
| 5 |
Merck
MRK
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$881M |
| 2 |
Blackstone
BX
|
+$367M |
| 3 |
Toronto Dominion Bank
TD
|
+$297M |
| 4 |
Scotiabank
BNS
|
+$264M |
| 5 |
Netflix
NFLX
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.8% |
| 2 | Miscellaneous | 15.16% |
| 3 | Technology | 10.24% |
| 4 | Energy | 8.8% |
| 5 | Industrials | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3376
Camden National
CAC
$953M
| $94K | ﹤0.01% |
2,043
+1,980
| +3,143% | +$86.5K |
2015 Q4
14 quarters
|
|
3377
iShares US Transportation ETF
IYT
$2.04B
| $94K | ﹤0.01% |
2,012
+324
| +19% | +$15.3K |
2013 Q2
24 quarters
|
|
3378
Global X Lithium & Battery Tech ETF
LIT
$1.43B
| $94K | ﹤0.01% |
3,600
+256
| +8% | +$6.89K |
2013 Q2
24 quarters
|
|
3379
Douglas Dynamics
PLOW
$916M
| $94K | ﹤0.01% |
2,367
+1,887
| +393% | +$71.8K |
2015 Q4
14 quarters
|
|
3380
Vanguard S&P 500 Value ETF
VOOV
$6.55B
| $94K | ﹤0.01% |
+833
| New | +$92.1K |
2019 Q2
0 quarters
|
|
|
ZYNE
3381
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $94K | ﹤0.01% |
+6,956
| New | +$80.3K |
2019 Q2
0 quarters
|
|
3382
Bloom Energy
BE
$81.8B
| $93K | ﹤0.01% |
7,651
+5,729
| +298% | +$70.3K |
2018 Q3
3 quarters
|
|
3383
MYR Group
MYRG
$4.64B
| $93K | ﹤0.01% |
2,488
-2,680
| -52% | -$93.3K |
2016 Q1
13 quarters
|
|
|
RMAX
3384
DELISTED
RE/MAX Holdings
RMAX
| $93K | ﹤0.01% |
2,982
+1,013
| +51% | +$36.4K |
2013 Q4
22 quarters
|
|
|
SHOE
3385
Shoe Station Group
SHOE
$345M
| $93K | ﹤0.01% |
6,740
+1,558
| +30% | +$24.2K |
2014 Q4
18 quarters
|
|
3386
MGP Ingredients
MGPI
$276M
| $92K | ﹤0.01% |
1,392
+1,090
| +361% | +$76.7K |
2018 Q2
4 quarters
|
|
3387
Powell Industries
POWL
$6.94B
| $92K | ﹤0.01% |
7,233
+2,250
| +45% | +$25.1K |
2013 Q2
24 quarters
|
|
|
ITCI
3388
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $92K | ﹤0.01% |
7,067
+3,771
| +114% | +$48.4K |
2015 Q3
15 quarters
|
|
|
HZNP
3389
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $92K | ﹤0.01% |
3,831
+1,201
| +46% | +$30.5K |
2014 Q1
21 quarters
|
|
3390
Hingham Institution for Saving
HIFS
$624M
| $91K | ﹤0.01% |
458
+125
| +38% | +$23.1K |
2015 Q3
15 quarters
|
|
3391
Koppers
KOP
$855M
| $91K | ﹤0.01% |
3,088
+1,590
| +106% | +$44.3K |
2013 Q2
24 quarters
|
|
|
BINI
3392
DELISTED
Bollinger Innovations
BINI
| – | – |
0
| – | – |
2018 Q4
2 quarters
|
|
3393
PJT Partners
PJT
$3.59B
| $91K | ﹤0.01% |
2,252
+1,954
| +656% | +$79.6K |
2015 Q4
14 quarters
|
|
3394
SiriusPoint
SPNT
$2.84B
| $91K | ﹤0.01% |
8,704
+6,849
| +369% | +$73.3K |
2018 Q1
5 quarters
|
|
|
SOLY
3395
DELISTED
Soliton, Inc.
SOLY
| $91K | ﹤0.01% |
+6,183
| New | +$79.9K |
2019 Q2
0 quarters
|
|
|
BITA
3396
DELISTED
Bitauto Holdings Limited
BITA
| $91K | ﹤0.01% |
8,626
-7,900
| -48% | -$95.5K |
2013 Q3
23 quarters
|
|
|
CKH
3397
DELISTED
Seacor Holdings Inc.
CKH
| $91K | ﹤0.01% |
1,925
+1,473
| +326% | +$64.7K |
2013 Q2
24 quarters
|
|
3398
Agilysys
AGYS
$2.83B
| $90K | ﹤0.01% |
4,192
+1,418
| +51% | +$29.4K |
2013 Q2
24 quarters
|
|
3399
Cytokinetics
CYTK
$9.12B
| $90K | ﹤0.01% |
7,949
+4,628
| +139% | +$44.6K |
2015 Q3
15 quarters
|
|
3400
MicroSectors FANG+ Index 2X Leveraged ETNs due 8 Jan 2038
FNGO
$788M
| $90K | ﹤0.01% |
11,795
-21,020
| -64% | -$170K |
2018 Q3
3 quarters
|
|
Similar funds
Bank of Montreal's Q2 2019 Portfolio in Review
As of Q2 2019, Bank of Montreal held 5,259 positions worth $119B, up 1.9% from $117B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Bank of Montreal's Q2 2019 filing shows 822 new, 2,226 increased, 1,465 reduced and 324 closed positions. Its largest new stake was Dow Inc: 1,346,158 shares worth $66.4M. The largest sale was Apple, an estimated $881M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Miscellaneous and Technology.
- Bank of Montreal's largest Q2 2019 buy was Dow Inc: 1,346,158 shares worth $66.4M.
- Bank of Montreal added most to Mastercard in Q2 2019, an estimated $194M increase.
- Bank of Montreal's biggest Q2 2019 reduction was Apple, cutting an estimated $881M.
- Bank of Montreal fully exited Goldcorp Inc in Q2 2019, selling an estimated $93M.
- Bank of Montreal's ten largest holdings make up 22% of its $119B portfolio in Q2 2019.
- Bank of Montreal opened 822 new positions and closed 324 in Q2 2019.
- Bank of Montreal's portfolio value rose 1.9% quarter-over-quarter to $119B.
Based on Bank of Montreal's 13F filing for Q2 2019, filed 9 Aug 2019.